Clarification relating to the Lanstead Sharing Agreement and further information on the China joint venture. Versarien plc, the advanced materials engineering group, is, pleased to provide further examples, following press comment, in respect of the subscription and sharing agreement with Lanstead Capital Investors LP, announced on 23 March 2020 and...
RNS Number: 6287 I Versarien PLC 02 April 2020 2 April 2020. Versarien plc, the advanced materials engineering group, would like to announce that following the Subscription and Sharing Agreement announced on 23 March 2020 and the associated increase in the total voting rights of the Company, Neill Ricketts, Chairman and CEO of Versarien, is now interested in...
RNS Number: 2329 I Versarien PLC 31 March 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2292 I Versarien PLC 31 March 2020. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1226 I Versarien PLC 31 March 2020 31 March 2020. Versarien plc, the advanced materials engineering group, announces, that that in conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company's issued share capital consists of 169,682,290 Ordinary Shares of 1 p each with full voting rights..
RNS Number: 9547 H Versarien PLC 30 March 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9160 H Versarien PLC 27 March 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9152 H Versarien PLC 27 March 2020. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7131 H Versarien PLC 26 March 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7109 H Versarien PLC 26 March 2020. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5950 H Versarien PLC 25 March 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5942 H Versarien PLC 25 March 2020. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Versarien #VRS 40.8p, Mkt cap £63m - Joint venture agreement signed with Young-Graphene Technology in China Versarien plc report the signing of a joint venture agreement Young-Graphene Technology Company Limited… Young Group has appointed the Secretary General of the China International Graphene Industry Union ‘CIGIU’ to act for it in this matter and is supported by both CIGIU and Beijing Institute of Graphene Technology Co. Ltd ‘BIGT’. The venture agrees to form a 50% owned Chinese jv to develop applications for Versarien’s graphene technologies in China. Versarien and Young Group will each put RMB1m (£121,000) into the joint venture over the next 12 months. The jv will have exclusive use of Versarien’ s technologies and intellectual property in China. *SP Angel act as nomad and broker to Vesarien plc
Versarien Plc #VRS announced an update on its progress in China, previously announced on 15 April 2019 and referenced in more recent company announcements including those on 9 August 2019, 24 September 2019, 12 December 2019 and 25 February 2020. Agreement has been signed with YG to form a 50%- owned Chinese Joint Venture (the "Joint Venture" or "JV") for the development of applications for Versarien's technologies in the region. YG and VGHK will each subscribe to an increase in the share capital of BVT, in an amount of RMB1 million (approximately £121,000) each so that VGHK and YG shall each hold 50% of BVT's registered share capital. BVT will retain its name as Beijing Versarien Technology Co., Ltd ("BVT"). Versarien will grant exclusivity to BVT for the use and promotion of the Versarien Technologies in the PRC providing certain terms are met in relation to a placing of new ordinary shares of Versarien. The terms and conditions of the Head License Agreement and those of the Sub-License Agreement shall be the same except that the license fees (including related technical service fees) under the Head License Agreement shall be 70% of the license fees under the SubLicense Agreement. The remaining 30% of the license fees under the Sub-License Agreement will be retained by BVT to fund its operating and management costs.
RNS Number: 5521 H Versarien PLC 25 March 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Versarien Plc
VRS.L
Versarien Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    153.62M

Featured Media

Company Profile

We utilise proprietary materials technology to create innovative engineering solutions that are capable of having game-changing impact in a broad variety of industry sectors. Founded in 2010, we have continued to develop advanced materials and processes to satisfy customer-specific applications whilst expanding our portfolio of intellectual property through acquisition. Our product offerings are capable of having a game-changing impact in a broad variety of industry sectors.

Classification

Market Indices-

Locations

HQ
2 Chosen View Road
Cheltenham
GL51 9LT
Watchlist